Phosphorothioate oligonucleotides induction into experimental choroidal neovascularization by HVJ-liposome system

References

• Macular photocoagulation study group. Argon laser pho-tocoagulation for senile macular degeneration. Results of randomized clinical trial. iArch Ophthalmoli 1982; 100:912–918.
   PubMed Web of Science ®Google Scholar
• Mainster MA. Laser thera py for neovascular macular degeneration: Analysis of mechanics. iLaser and Light in Ophthalmoli 1987;1:167–176.
   Google Scholar
• Chakaravarthy U, Houston RF, Archer D. Treatment of age-related subfoveal neovascular membranes by tele-therapy : a pilot study. iBrit J Ophthalmol.i 1993; 77: 265–273.
   Google Scholar
• Finger PT, Berson A, Sherr D, Riely R, Balkin RA, Bosworth JL. Radiation therapy for subretinal neovas-cularization. iOphthalmologyi 1996; 103:878–889.
   PubMed Web of Science ®Google Scholar
• Holekamp NM, Thomas MA, Dickinson JD, Valluri S. Surgical removal of subfoveal choroidal neovasculari-zation in presumed ocular histoplasmosis. Stability of early visual results. iOphthalmologyi 1997; 104:473–479
   Google Scholar
• Stalmans P, Leys A, Limbergen EV. External beam ra-diotherapy (20 Gy, 2 Gy fractions) fails to control the growth of choroidal neovascularization in age-related macular degeneration: a review of 111 cases. iRetinai 1997;17: 481–492.
   Google Scholar
• Green WR, Enger C. Age-related macular degeneration. Histopathologic studies. iOphthalmology.i 1993;100: 1519–1535.
   Google Scholar
• Lutty GA, Chandler C, Bennett A, Fait C, Patz A. Pres-ence of endothelial cell growth factor activity in normal and diabetic eyes. iCurr Eye Res.i 1986;5:9–17.
   Google Scholar
• Miller JW, Adamis AP, Shima DT, D'Amore PA, Moulton RS, O'Reilly MS, Folkman J, Dvorak HF, Brown LF, Berse B, Yeo T-K, Yeo K-T. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. iAm J Pathologyi 1994;145: 574–584.
   Google Scholar
• Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shan ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, King GL. Vas-cular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. iN Engl J Med.i 1994;331:1480–1487.
   PubMed Web of Science ®Google Scholar
• Piece EA, Avery RL, Foley ED, Aiello LP, Smith LEH. Vascular endothelial growth factor /vascular permeabil-ity factor expression in a mouse model of retinal neo-vascularization. iProc natl Acad Sci USA.i 1995;92: 905–909.
   Google Scholar
• Ogata N, Matsushima M, Takada Y, Tobe T, Takahashi K, Yi X, Yamamoto C, Miyashiro M, Yamada H, UyamaM. Expression of fibroblast growth factor mRNA in developing choroidal neovascularization. iCurr Eye Res.i 1996;15:1009–1018.
   Google Scholar
• Matsushima M, Ogata N, Takada Y, Tobe T, Yamada H, Takahashi K,Uyama M. Expression of fibroblast growth factor receptor 1 in experimental choroidal neovascularization with iin situi hybridization. iJ Jpn Ophthalmol.i 1996;40: 329–338.
   Google Scholar
• Ogata N, Yamamoto C, Miyashiro M, Yamada H, Matsushima M, Uyama M. Expression of transforming growth factor-J3 mRNA in experimental choroidal neovascularization. iCurrent Eye Res.i 1997;16:9–18.
   PubMed Web of Science ®Google Scholar
• Kliffen M, Sharman HS, Mooy CM, Kerkvliet S, de Jong P TVM. Increased expression of angiogenic growth fac-tors in age-related maculopathy. iBrit J Ophthalmol.i 1997;81:154–162.
   Google Scholar
• Yi XJ, Ogata N, Komada M, Yamamoto C, Takahashi K, Omori K, Uyama M. Vascular endothelial growth factor expression in choroidal neovascularization. iGraefe's Arch Clin Exp Ophthalmol.i 1997;235:313–319.
   Google Scholar
• Wada M, Ogata N, Otsuji T, Uyama M. Expression of Vascular Endothelial Growth Factor and its receptor (KDR/flk-1) mRNA in Experimental Choroidal Neovas-cularization. iCurrent Eye Res.i 1999;18: in press.
   Google Scholar
• Frank RN, Das A, Weber ML. A model of subretinal neovascularization in the pigmented rat. iCurr Eye Res.i 1989;8:239–247.
   PubMed Web of Science ®Google Scholar
• Ledley FD. Nonviral gene therapy: The promise of genes as pharmaceutical products. iHum Gene Ther.i 1995;6: 1129–1144.
   PubMed Web of Science ®Google Scholar
• Saeki Y, Kaneda Y. Protein-Mediated liposomes (HVJ-liposomes) for the delivery of gene, oligonucleotides, and proteins. Cell Biology; a laboratory handbook, 2nd ed. JE Celis ed. Academic press Vol 4,123–130,1998.
   Google Scholar
• Saeki Y, Matsumoto N, Nakano Y, Mori M, Awai K, Kaneda Y. Development and Characterization of cationic liposomes conjugated with HVJ (sendai virus) : Recip-rocal effect of cationic lipid for iin vitroi and iin vivoi gene transfer. Human gene Therapy 8;1997: 1965-1972.
   Google Scholar
• Morishita R, Gibbons GH, Kaneda Y, Ogihara T, Dzau VJ. Pharmacokinetics of antisense oligodeoxyribonucleo-tides (cyclin B1 and CDC 2 kinase) in the vessel wall in vivo: enhanced therapeutic utility for restenosis by HVJ-liposome delivery. Gene. 1994;149: 13–19.
   Google Scholar
• Kato K, Yoneda Y, Okada Y, Kiyama H, Shiosaka S. Gene transfer and the expression of a foreign gene iin vivoi in post-mitotic neurons of adult rat brain using he-magglutinating virus of the Japan-liposome method. iMol Brain Res.i 1994;25:359–363.
   Google Scholar
• Tomita N, Higaki J, Morishita R, Kato K, Mikami H, Kaneda Y, Ogihara T. Direct iin vivoi gene introduction into rat kidney. iBiochem Biophys Res Commum.i 1992; 186:129–134.
   Google Scholar
• Von der Leyen HE, Gibbons GH, Morishita R, Lewis NP, Zhang L, Nakajima M, Kaneda Y, Cooke JP, Dzau VJ. Gene therapy inhibiting neointimal vascular lesion: iIn vivoi transfer of endothelial cell nitric oxide synthase gene. iProc Natl Acad Sci USA.i 1995; 92:1137–1141.
   PubMed Web of Science ®Google Scholar
• Hangai M, Kaneda Y, Tanihara H, Honda Y. In ivivoi gene transfer into the retina mediated by a novel liposome system. iInvest Ophthalmol Vis Sci.i 1996;37: 2678–2685.
   Google Scholar
• Hangai M, Tanihara H, Honda Y, Kaneda Y. Introduc-tion of DNA into the rat and primate trabecular mesh-work by fusogenic liposomes. iInvest Ophthalmol Vis Sci.i 1998;39:509–516.
   Google Scholar
• Agrawal SA. Antisense oligonucleotides as antiviral agents. iTrends Biothechnol.i 1992;10:152–158.
   PubMed Web of Science ®Google Scholar
• Wagner RA. Gene inhibition using antisense oligodeoxy-nucleotides. iNaturei 1994;372:333–335.
   Google Scholar
• Stein CA, Chang YC. Antisense oligonucleotiddes as therapeutic agents-Is the bullet really magical? iSciencei 1993;261:1004–1012.
   PubMed Web of Science ®Google Scholar
• Kaneda Y, Morishita R, Tomita N. Increased expression of DNA cointroduced with nuclear protein in adult rat liver. iJ Mol Med.i 1995;73:289–297
   Google Scholar
• Tomita N, Morishita R, Higaki J, Aoki M, Nakamura Y, Mikami H, Fukamizu A, Murakami K, Kaneda Y, Ogihara T. Transient decrease in high blood pressure by iin vivoi transfer of antisense oligodeoxynucleotides against rat angiotensinogen. iHypertension.i 1995;26: 131–136.
   PubMed Web of Science ®Google Scholar
• Morishita R, Gibbons G, Ellison KE, Nakajima M, Zhang L, Kaneda Y, Ogihara T, Dzau VJ. Single intraluminal delivery of antisense cdc2 kinase and proliferating-cellnuclear antigen oligonucleotides results in chronic inhi-bition of neointimal hyperplasia. iProc Natl Acad Sci USA.i 1993;90:8474–8478.
   PubMed Web of Science ®Google Scholar
• Conn G, Bayne ML, Soderman DD, Kwok PW, Sullivan KA, Palisi TM, Hope DA, Thomas KA. Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. iProc Natl Acad Sci USA.i 1990;87:2628–2632.
   PubMed Web of Science ®Google Scholar
• Kittelberger R, Davis PF, Stehbens WE. An improved immunofluorecence technique for the histological exami-nation of blood vessel tissue. iActa Histochem.i 1989; 86:137–142.
   Google Scholar
• Hangai M, Tanihara H, Honda Y, Kaneda iY. In vivoi delivery of phosphorothioate oligonucleotides into mu-rine retina. iArch Ophthalmoli 1998;116:342–348.
   Google Scholar
• Morishita R, Gibbons GH, Ellison KE, Nakajima N, von der Leyen H, Zhang L, Kaneda Y, Ogihara T, Dzau VJ. Initial hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. iJ Clin Investi 1994;93:1458–1464.
   Google Scholar
• Bennett J, Wilson J, Sun D, Forbes B, Maguire A. Ade-novirus vector-mediated iin vivoi gene transfer into adult murine retina. iInvest Ophthalmol Vis Scii 1994;35: 2535–2543.
   PubMed Web of Science ®Google Scholar
• Jomary C, Piper TA, Dickson G, Couture LA, Smith AE, Neal MJ, Jones SE. Adenovirus-mediated gene transfer to murine retinal cells iin vitroi and iin vivo.i FEBS 1994;347:117–122.
   Google Scholar
• Stern WH, Heath TD, Lewis GP, Guerin CJ, Erickson PA, Lopez NG, Hong K. Clearance and localization of intravitreal liposomes in the aphakic vitrectomized eye. iInvest Ophthalmol Vis Scii 1987;28:907–911.
   Google Scholar
• Murata T, Hangai M, Ishibashi T, Spee C, Gordon EM, Anderson WF, Spee C, Hinton DR, Ryan SJ. Retrovirus -mediated gene transfer to photocoagulation-induced choroidal neovascular membrane. iInvest Ophthalmol Vis Sci,i 1998;39:2474–2478.
   Google Scholar
• Aiello LP, Pierce EA, Robinson GS, Ferrara N, Smith LEH. Vascular endothelial growth factor (VEGF) antago-nists inhibit retinal neovascularization. iDiabetesi 1995;44:53 (abstract).
   Google Scholar
• Kim KJ, Li B, Winer J. Armanini M, Gillett N, Phillips HS, Ferrara N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth iin vivo. Naturei 1993;362:841–844.
   Google Scholar
• Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A. Glioblastoma growth inhibited iin vivoi by a dominant-negative Flk-1 mutant. iNaturei 1994; 367:576–579.
   Google Scholar
• Cheng SY, Huang HJS, Nagane M, Ji XD, Wang D, Shih CCY, Arap W, Huang CM, Cavenee WK. Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endo-thelial growth factor. iProc Natl Acad Sci USA.i 1996; 93:8502–8507.
   Google Scholar
• Ellis LM, Liu W, Wilson M. Down-regulation of vas-cular endothelial growth factor in human colon carcinomacell lines by antisense transfection decreases endothe-lial cell proliferation. iCancer Res.i 1996;102: 871–878.
   Google Scholar
• Saleh M, Stacker SA, Wilks AF. Inhibition of growth of C6 glioma cells iin vivoi by expression of antisense vascular endothelial growth factor sequence. iCancer Res.i 1996;56: 393–401.
   Google Scholar
• Chen ZQ, Fisher RJ, Riggs CW, Rhim JS, Lautenberger JA. Inhibition of vascular endothlial growth factor-in-duced endothelial cell migration by ETS1 antisense oli-gonucleotides. iCancer Res.i 1997;57: 2013–2019.
   Google Scholar
• Robinson GS, Pierce EA, Rook SL, Foley E, Webb R, Smith LEH. Oligodeoxynucleotides inhibit retinal neo-vascularization in a murine model of proliferative retin-opathy. iProc Natl Acad Sci USA.i 1996;4850–4856.
   Google Scholar